Madrid, Spain–(ENEWSPF)–21 January 2011. The combined administration of THC and the pharmaceutical agent temozolomide (TMZ) demonstrates strong anti-cancer activity in brain tumors resistant to conventional anti-cancer treatments, according to preclinical data published online in the journal Molecular Cancer Therapeutics.
Investigators at Complutense University in Spain assessed the anti-tumor activity of the cannabinoids THC and CBD (cannabidiol) in glioma xenografts (tissue grafts).
Authors reported that the administration of THC in combination with TMZ (the benchmark…
